November 2nd, 2011 by RamonaBatesMD in Research
1 Comment »
I happened to see this press release from American Society of Nephrology via Eurekalert regarding an article in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN) advocating the safety of kidney donation in individuals over 70 years old. The press release does note that kidneys from these elderly donors do not last as long as those from younger living donors.
Currently, as noted on the University of Maryland Medical Center website:
Donors need to be between the ages of 18 and early 70s and can include parents, children, siblings, other relatives, and friends. An ideal donor should have a genuine interest in donating and a compatible blood type with the recipient.
Donors should be in good general health. Donors do not need to be Read more »
*This blog post was originally published at Suture for a Living*
November 2nd, 2011 by ChristopherChangMD in Opinion, Research
No Comments »
I read with astonishment that a class of cancer drugs known as VEGF Inhibitors (ie, Avastin and Erbitux) used to treat colorectal, lung, breast, and kidney cancers can also be used to potentially treat a type of chronic ear infection known as glue ear… at least in theory and in mice. Glue ear is when an individual suffers from repetitive ear infections or upper respiratory infections to the point where the fluid in the ear turns into a maple syrup consistency. It’s thick, sticky and tough to get rid of with standard antibiotic medications. Standard treatment to address glue ear is placement of ear tubes to allow ventilation and drainage of the ear as well as antibiotic/steroid ear drops.
British researchers using the mouse model have determined that Read more »
*This blog post was originally published at Fauquier ENT Blog*
November 1st, 2011 by RyanDuBosar in Research
1 Comment »
Physicians need at least three to five days of training on new electronic health record (EHR) systems to achieve the highest level of overall satisfaction, but nearly half of new users get three or fewer days of training, according to a survey.
AmericanEHR Partners surveyed physicians’ experiences with EHRs to achieve some meaningful use requirements. (The group is a web-based resource for EHR system selection/implementation developed by the American College of Physicians and Cientis Technologies).
AmericanEHR Partners used a 139-question online survey to collect data form physicians, nurse practitioners and physician assistants about their use and satisfaction with EHRs and health information technology. Survey data from more than 2,300 physicians in conjunction with five different professional societies was collected from April 2010 to July 2011. Results appeared at the group’s website.
There were Read more »
*This blog post was originally published at ACP Internist*
October 31st, 2011 by RyanDuBosar in Research
No Comments »
Providing information of imminent death to cancer patients does not increase pain or anxiety, but is associated with improved care and to increase the likelihood of fulfilling the principles of a good death, a Swedish study found.
Informed patients significantly more often had parenteral drugs prescribed as needed, died in his or her preferred place, and had an informed family who were offered bereavement support. There was no difference between informed and uninformed patients in control of pain, anxiety, nausea, and respiratory tract secretions, although there was a difference in management of confusion. Results appeared in the Journal of Clinical Oncology.
Since 2000, there has been an increasing focus on palliative care in Sweden, the study authors wrote. In 2001, the Swedish Government identified breakpoints for Read more »
*This blog post was originally published at ACP Hospitalist*
October 30th, 2011 by GarySchwitzer in News, Research
No Comments »
Reporter John Fauber has published the latest in his “Side Effects” watchdog series, headlined “Doctors didn’t disclose spine product cancer risk in journal: Spine-product paper omitted key data.” Excerpts:
“Doctors paid millions of dollars by Medtronic failed to identify a significant cancer risk with the company’s spine surgery product in a 2009 paper about results of a large clinical trial.
The surgeons left out important data and claimed there was no significant link between the product and cancer.
The company and doctors had become aware of information on Read more »
*This blog post was originally published at Gary Schwitzer's HealthNewsReview Blog*
